Arthneeti
Latest: Deepak Nitrite Q2 FY27 (Jul–Sep 2026) results →This page is Q1 FY27 (Apr–Jun 2026).All Q1 FY27 results →
DN

Deepak Nitrite

Q1 FY27Chemicals & Petrochemicals

Deepak Nitrite Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹1,749
Market cap₹23.8K Cr
P/E30.1
Updated25 Aug 2026
Read4 min read

What the Q1 FY27 call signalled

3 of 4 strong

RevenueGood growth
MarginMargins steady
CapexCapex planned
FundraiseFundraise planned

The short version

Strong start to FY27 with record quarterly revenue of INR 2,592 crore, a 35% YoY and 22% QoQ growth. Deepak Nitrite records highest-ever quarterly Revenue, EBITDA, PBT, and PAT in Q1 FY27, indicating strong growth momentum.

From Deepak Nitrite's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Good growth
  • Strong start to FY27 with record quarterly revenue of INR 2,592 crore, a 35% YoY and 22% QoQ growth.
  • Increasing volumes supported by improved demand across key end-user industries and new product introductions.
  • Capacity expansion in phenol plant targeting a run rate of 4 lakh tonnes annually; aiming to reach 1 lakh tonnes quarterly phenol production.
  • Ongoing commissioning of MIBK, MIBC, acetophenone projects to broaden product basket and support margin expansion.
  • Focus on value-added products in Advanced Intermediates with improved margins expected.
  • Continued ramp-up of recently commissioned assets and expected higher asset utilization.
  • Domestic business remains resilient with 85% revenue, exports growing steadily.

2 more points from Deepak Nitrite's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Deepak Nitrite said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Ongoing capex of approximately INR 3,500 crore planned for the current year focused on site development, construction, and setting up imported assets (Page 15).
  • Total capex spent till now (last year and this year combined) around INR 3,000 crore; additional INR 3,000 crore planned for 2027-28 (Page 15).
  • INR 11,500 crore capex for integrated propylene and polycarbonate project funded with 60:40 debt-to-equity ratio; debt funding already tied up at competitive rates (Page 7).
  • Approximately INR 1,200 crore already spent this year; pending capex of INR 1,000-1,500 crore this year (Page 14).
  • Investments include debottlenecking and capacity expansions in phenol plant (aiming for 4 lakh tonnes), commissioning of acetophenone facility, and commissioning hydrogenation and nitration facilities (Pages 9, 15, 19).

2 more points from Deepak Nitrite's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Deepak Nitrite said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Deepak Nitrite said on order book & pipeline — free account, 30 seconds.

Deepak Nitrite — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹3.1K Cr, net profit ₹398 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Deepak Nitrite Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Alufluoride (Q1 FY27)

    Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr

  • POCL Enterprises (Q1 FY27)

    466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto

  • Devson Catalyst (Q1 FY27)

    FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee

  • Ambani Orgochem (Q1 FY27)

    Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Deepak Nitrite and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Deepak Nitrite Q1 FY27 results?

Strong start to FY27 with record quarterly revenue of INR 2,592 crore, a 35% YoY and 22% QoQ growth. Deepak Nitrite records highest-ever quarterly Revenue, EBITDA, PBT, and PAT in Q1 FY27, indicating strong growth momentum.

What is Deepak Nitrite share price analysis?

Deepak Nitrite currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 30.1 with a market cap of ₹23,829 Cr. Investors should review the full earnings analysis for detailed insights.

Is Deepak Nitrite planning capital expenditure?

Ongoing capex of approximately INR 3,500 crore planned for the current year focused on site development, construction, and setting up imported assets (Page 15).

Keep Deepak Nitrite on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.